Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prilosec 1 Use For GERD Endorsed In 16-2 Joint Committee Vote

This article was originally published in The Tan Sheet

Executive Summary

Possible long-term use of omeprazole to prevent chronic heartburn or gastroesophageal reflux disease (GERD) is acceptable, despite an OTC indication for only 14-day use, FDA advisory committee members determined at a meeting in Bethesda, Md. June 21

You may also be interested in...



Some OTC Switch Benefits Are Intangible, But Influential – CDER’s Ganley

Non-measurable benefits can tip the scales in the benefit-risk consideration of an OTC switch NDA, suggests Charles Ganley, director of CDER's Office of Drug Evaluation. One way to look at non-measurable benefits is OTC ingredients "lower the threshold” for patient “misery” prior to seeking relief, he says.

Some OTC Switch Benefits Are Intangible, But Influential – CDER’s Ganley

Non-measurable benefits can tip the scales in the benefit-risk consideration of an OTC switch NDA, suggests Charles Ganley, director of CDER's Office of Drug Evaluation. One way to look at non-measurable benefits is OTC ingredients "lower the threshold” for patient “misery” prior to seeking relief, he says.

Pricing Strategy Can Help Brands Regain Share Lost To Private Label – Expert

Branded products manufacturers have an array of pricing strategies available to help them regain market share lost to private label during the economic recession, a market researcher says.

Related Content

Topics

UsernamePublicRestriction

Register

PS094186

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel